drug · antibody
toripalimab
Phase 2updated 3mo agoby $CHRS Coherus Oncology, Inc.🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 3Antibody drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 52 investigational indications.
indications
indications
Melanoma
targets
Programmed cell death protein 1
all catalysts(1)
Trials studying toripalimab
- EP1An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
- phase4A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
- phase2Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
- EP1An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
- phase3LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
- phase2A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung CancerInhibitors or Platinum-Based Agents for Small Cell Lung Cancer.
- phase1A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
- phase2Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that